ATE221083T1 - Glialmitogene faktoren, ihre herstellung und verwendung - Google Patents
Glialmitogene faktoren, ihre herstellung und verwendungInfo
- Publication number
- ATE221083T1 ATE221083T1 AT92907539T AT92907539T ATE221083T1 AT E221083 T1 ATE221083 T1 AT E221083T1 AT 92907539 T AT92907539 T AT 92907539T AT 92907539 T AT92907539 T AT 92907539T AT E221083 T1 ATE221083 T1 AT E221083T1
- Authority
- AT
- Austria
- Prior art keywords
- factors
- glialmitogenic
- production
- factor
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919107566A GB9107566D0 (en) | 1991-04-10 | 1991-04-10 | Glial mitogenic factors,their preparation and use |
PCT/GB1992/000595 WO1992018627A1 (en) | 1991-04-10 | 1992-04-03 | Glial mitogenic factors, their preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE221083T1 true ATE221083T1 (de) | 2002-08-15 |
Family
ID=10692987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92907539T ATE221083T1 (de) | 1991-04-10 | 1992-04-03 | Glialmitogene faktoren, ihre herstellung und verwendung |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0579640B1 (de) |
JP (1) | JPH06507544A (de) |
KR (1) | KR100274305B1 (de) |
AT (1) | ATE221083T1 (de) |
AU (2) | AU1450992A (de) |
CA (1) | CA2108119C (de) |
DE (1) | DE69232693T2 (de) |
DK (1) | DK0579640T3 (de) |
GB (1) | GB9107566D0 (de) |
IE (1) | IE921062A1 (de) |
PT (1) | PT100344B (de) |
WO (1) | WO1992018627A1 (de) |
ZA (1) | ZA922441B (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5530109A (en) * | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
IL101943A0 (en) * | 1991-05-24 | 1992-12-30 | Genentech Inc | Structure,production and use of heregulin |
US5367060A (en) * | 1991-05-24 | 1994-11-22 | Genentech, Inc. | Structure, production and use of heregulin |
US5834229A (en) | 1991-05-24 | 1998-11-10 | Genentech, Inc. | Nucleic acids vectors and host cells encoding and expressing heregulin 2-α |
JPH08500246A (ja) * | 1992-08-10 | 1996-01-16 | ケンブリッジ ニューロサイエンス インコーポレーテッド | 細胞増殖の阻害剤,その調製および用途 |
GB9217316D0 (en) * | 1992-08-14 | 1992-09-30 | Ludwig Inst Cancer Res | Schwann cell mitogenic factor,its preparation and use |
US5770567A (en) * | 1994-11-14 | 1998-06-23 | Genentech, Inc. | Sensory and motor neuron derived factor (SMDF) |
US5849585A (en) * | 1995-05-10 | 1998-12-15 | Genetech, Inc. | Isolating and culturing Schwann cells |
US5721139A (en) * | 1995-05-10 | 1998-02-24 | Genentech, Inc. | Isolating and culturing schwann cells |
US6033660A (en) * | 1995-05-10 | 2000-03-07 | Genentech, Inc. | Method of treating a nervous system injury with cultured schwann cells |
US5912326A (en) * | 1995-09-08 | 1999-06-15 | President And Fellows Of Harvard College | Cerebellum-derived growth factors |
DE69732711T2 (de) | 1996-07-12 | 2006-03-16 | Genentech, Inc., South San Francisco | Gamma-heregulin |
US6136558A (en) * | 1997-02-10 | 2000-10-24 | Genentech, Inc. | Heregulin variants |
DK0970207T3 (da) | 1997-02-10 | 2009-07-13 | Genentech Inc | Heregulin-varianter |
WO1999031505A1 (en) * | 1997-12-15 | 1999-06-24 | Shire Laboratories Inc. | Neurotrophic factor assay |
US20010023241A1 (en) | 1998-02-04 | 2001-09-20 | Sliwkowski Mark X. | Use of heregulin as a growth factor |
AUPP785098A0 (en) | 1998-12-21 | 1999-01-21 | Victor Chang Cardiac Research Institute, The | Treatment of heart disease |
US6635249B1 (en) | 1999-04-23 | 2003-10-21 | Cenes Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
ITMI20011057A1 (it) * | 2001-05-22 | 2002-11-22 | Bracco Imaging Spa | Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi |
WO2003099320A1 (en) | 2002-05-24 | 2003-12-04 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
US7241392B2 (en) | 2004-09-09 | 2007-07-10 | Dresser-Rand Company | Rotary separator and method |
US20070213264A1 (en) | 2005-12-02 | 2007-09-13 | Mingdong Zhou | Neuregulin variants and methods of screening and using thereof |
RU2457854C2 (ru) | 2005-12-30 | 2012-08-10 | Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи Лимитед | Длительное высвобождение нейрегулина для улучшения сердечной функции |
CN107041949A (zh) | 2008-08-15 | 2017-08-15 | 阿索尔达治疗公司 | 在cns神经性损伤后非‑急性期间处理的组合物及方法 |
WO2013053076A1 (en) | 2011-10-10 | 2013-04-18 | Zensun (Shanghai)Science & Technology Limited | Compositions and methods for treating heart failure |
BR112015029293A2 (pt) | 2013-05-22 | 2018-04-24 | Zensun Shanghai Science & Tech Ltd | método e kit para prevenir, tratar ou retardar uma doença ou distúrbio cardiovascular em um mamífero |
-
1991
- 1991-04-10 GB GB919107566A patent/GB9107566D0/en active Pending
-
1992
- 1992-04-03 WO PCT/GB1992/000595 patent/WO1992018627A1/en active IP Right Grant
- 1992-04-03 ZA ZA922441A patent/ZA922441B/xx unknown
- 1992-04-03 DE DE69232693T patent/DE69232693T2/de not_active Expired - Lifetime
- 1992-04-03 DK DK92907539T patent/DK0579640T3/da active
- 1992-04-03 JP JP4506965A patent/JPH06507544A/ja active Pending
- 1992-04-03 PT PT100344A patent/PT100344B/pt not_active IP Right Cessation
- 1992-04-03 CA CA002108119A patent/CA2108119C/en not_active Expired - Lifetime
- 1992-04-03 EP EP92907539A patent/EP0579640B1/de not_active Expired - Lifetime
- 1992-04-03 KR KR1019930703120A patent/KR100274305B1/ko not_active IP Right Cessation
- 1992-04-03 AU AU14509/92A patent/AU1450992A/en not_active Abandoned
- 1992-04-03 AT AT92907539T patent/ATE221083T1/de active
- 1992-04-03 IE IE106292A patent/IE921062A1/en not_active IP Right Cessation
-
1996
- 1996-10-09 AU AU68083/96A patent/AU703772B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AU6808396A (en) | 1997-01-16 |
IE921062A1 (en) | 1992-10-21 |
DK0579640T3 (da) | 2002-11-11 |
CA2108119A1 (en) | 1992-10-11 |
DE69232693D1 (de) | 2002-08-29 |
AU1450992A (en) | 1992-11-17 |
WO1992018627A1 (en) | 1992-10-29 |
EP0579640B1 (de) | 2002-07-24 |
KR100274305B1 (ko) | 2000-12-15 |
EP0579640A1 (de) | 1994-01-26 |
JPH06507544A (ja) | 1994-09-01 |
DE69232693T2 (de) | 2003-04-03 |
AU703772B2 (en) | 1999-04-01 |
GB9107566D0 (en) | 1991-05-29 |
ZA922441B (en) | 1992-11-25 |
PT100344A (pt) | 1993-07-30 |
CA2108119C (en) | 2009-06-30 |
PT100344B (pt) | 1999-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69232693D1 (de) | Glialmitogene faktoren, ihre herstellung und verwendung | |
ATE139261T1 (de) | Muteine des menschlichen erythropoetins, ihre herstellung und ihre verwendung | |
DE69215434D1 (de) | 1,3,5-Triazinderivate, ihre Herstellung und ihre Verwendung als Lichtschutzmittel | |
DE69019550T2 (de) | Piperidin-Derivate, ihre Herstellung und ihre Verwendung. | |
DE3885534D1 (de) | Arylphosphorderivate, ihre Herstellung und Verwendung. | |
DE69008454T2 (de) | Nitrolsothiolderivate, ihre Herstellung und Verwendung. | |
DE68906011T2 (de) | Chitosan enthaltendes kosmetisches praeparat. | |
NZ225770A (en) | Compositions of substituted 1,2,3-triazoles | |
DE69204290D1 (de) | Verwendung von 1,2,2,3,3-pentafluorpropan. | |
DE59208576D1 (de) | 3-Isoxazolylphenylverbindungen, ihre Herstellung und ihre Verwendung | |
DE59409541D1 (de) | Bicyclen-derivate, ihre herstellung und verwendung | |
DE59606806D1 (de) | Polymerholz-formkörper, ihre herstellung und verwendung | |
ATE39694T1 (de) | (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung. | |
ATE113591T1 (de) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva. | |
DE68908389D1 (de) | Amidofluoroverbindungen, ihre herstellung und ihre verwendung. | |
DE68919259T2 (de) | N-Phenylimide, ihre Herstellung und Verwendung. | |
DE58906618D1 (de) | Strobilurinderivate, ihre Herstellung und Verwendung. | |
CA2001782A1 (en) | 3-(3-propan-2-ylphenyl) butanal and 3-(3-propen-2-ylphenyl) butanal and their use as odorants | |
ATE132500T1 (de) | 24r-scymnol, herstellung und verwendung | |
DE69212484D1 (de) | Herstellung von 1,1,1-trifluoro-2-chloroethan und/oder 1,1,1,2-tetrafluoroethan | |
ATE128867T1 (de) | Verwendung von 3-aryl-5-alkylthio-4h-1,2,4- triazolen zur behandlung von überreflexen infolge von rückenmarkstrauma. | |
DE69116057D1 (de) | Mikrobische Herstellung des 13-beta-13-deoxy-22,23,-dihydroavermectin-Bla/B1b-Aglycons | |
DE59202744D1 (de) | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung. | |
DE68910893T2 (de) | Alkenyltetrazole Derivate, ihre Herstellung und ihre Verwendung. | |
DE9308192U1 (de) | Lichtschutzzusammensetzungen, ihre Herstellung und ihre Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0579640 Country of ref document: EP |